A 28-year-old male trekker from Himachal Pradesh presents with a 10-day history of fever, headache, and generalized myalgia. He recalls being bitten by mites while camping in scrub forest 12 days ago. On examination, he has a maculopapular rash on the trunk and extremities (sparing palms and soles), a 1 cm × 1 cm black necrotic ulcer with surrounding erythema on the left thigh, and generalized lymphadenopathy. His temperature is 39.5°C, heart rate 110/min, and respiratory rate 28/min. Laboratory findings: WBC 8,500/μL, platelets 120,000/μL, ALT 280 U/L, creatinine 1.4 mg/dL. Chest X-ray shows bilateral interstitial infiltrates. What is the most appropriate initial antibiotic therapy?

Explanation

## Diagnosis and Treatment: Scrub Typhus ### Clinical Diagnosis **Key Point:** The pathognomonic **eschar** (necrotic ulcer with surrounding erythema at the mite bite site) is the single most discriminating sign of scrub typhus caused by *Orientia tsutsugamushi*. ### Why This Is Scrub Typhus | Feature | Scrub Typhus | Leptospirosis | Typhoid | |---------|--------------|---------------|--------| | **Eschar** | Yes (pathognomonic) | No | No | | **Rash pattern** | Maculopapular, centripetal (spares palms/soles) | Petechial, trunk | Rose spots (sparse) | | **Vector** | Mite (*Leptotrombidium*) in scrub | Water exposure | Fecal-oral | | **Lymphadenopathy** | Regional (generalized if disseminated) | Absent | Absent | | **Incubation** | 6–21 days (mean 10–12) | 2–30 days | 6–30 days | | **Conjunctival suffusion** | No | Yes, no exudate | No | **High-Yield:** The centripetal rash (starting on trunk, spreading to extremities but sparing palms/soles) + eschar + regional lymphadenopathy = scrub typhus until proven otherwise. ### Pathophysiology *Orientia tsutsugamushi* (formerly *Rickettsia tsutsugamushi*) is an obligate intracellular gram-negative coccobacillus transmitted by larval trombiculid mites. It causes: 1. Local eschar at inoculation site 2. Regional lymphadenopathy 3. Systemic dissemination → rash, fever, multi-organ involvement 4. Complications: myocarditis, ARDS, meningoencephalitis, acute kidney injury ### Why Doxycycline Is the Correct Choice **Clinical Pearl:** Doxycycline is the drug of choice for scrub typhus in both mild and severe disease. It is superior to other agents because: 1. **Excellent intracellular penetration:** Rickettsiae are obligate intracellular pathogens; doxycycline achieves high tissue concentrations 2. **Rapid defervescence:** Fever typically resolves within 24–48 hours of starting doxycycline 3. **Proven efficacy:** Mortality <1% with doxycycline vs. 5–10% without treatment 4. **Oral bioavailability:** Can be given orally even in moderate disease; IV formulation not required 5. **Cost-effective and widely available** **Dosing:** Doxycycline 100 mg BD × 7–10 days (or until 48 hours after defervescence) **Key Point:** Even in severe scrub typhus with interstitial pneumonia (as in this case), doxycycline remains first-line. IV formulations are not necessary unless the patient cannot tolerate oral intake. ### Antibiotic Comparison for Rickettsial Infections | Drug | Mechanism | Use in Scrub Typhus | Limitations | |------|-----------|---------------------|-------------| | **Doxycycline** | Protein synthesis inhibitor | **First-line, all severities** | Teratogenic; avoid in pregnancy <8 weeks | | **Chloramphenicol** | Protein synthesis inhibitor | Alternative in pregnancy | Bone marrow suppression; slower response | | **Ceftriaxone** | β-lactam (cell wall) | **NOT effective** | Rickettsiae lack cell walls; poor intracellular penetration | | **Penicillin G** | β-lactam (cell wall) | **NOT effective** | Rickettsiae lack cell walls; poor intracellular penetration | | **Fluoroquinolones** | DNA gyrase inhibitor | Limited data; not first-line | Inferior to doxycycline in clinical trials | **Warning:** β-lactams (cephalosporins, penicillins) are ineffective against rickettsiae because rickettsiae lack a cell wall. This is a common NEET PG trap. ### Management of Severe Scrub Typhus (This Patient) This patient has: - Interstitial pneumonia (bilateral infiltrates on CXR) - Tachypnea (RR 28/min) - Mild renal dysfunction (Cr 1.4 mg/dL) - Hepatitis (ALT 280 U/L) **Approach:** 1. **Start doxycycline 100 mg BD immediately** (oral is acceptable; IV not required) 2. **Supportive care:** Oxygen therapy, fluid management, monitoring for ARDS 3. **Monitor for complications:** Myocarditis, meningoencephalitis, disseminated intravascular coagulation (DIC) 4. **Repeat CXR in 48–72 hours** to assess response 5. **Defervescence expected within 24–48 hours** of starting doxycycline **Mnemonic: SCRUB TYPHUS DRUGS** — **S**tart **D**oxycycline, **A**void **B**eta-lactams, **C**hloramphenicol (pregnancy only), **R**ickettsiae (intracellular), **U**se **B**road coverage (supportive), **T**issue penetration (doxycycline), **Y**ield rapid response (24–48 hrs) ### Diagnostic Confirmation - **Weil-Felix test:** Heterophile agglutination (OX-K strain); positive in 50–80% (low sensitivity) - **IgM ELISA:** Gold standard; positive by day 5–7 - **PCR:** Positive in first week - **Culture:** Difficult; requires BSL-3 facility